Logo image of SNYR

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

USA - NASDAQ:SNYR - US87165D2080 - Common Stock

2.56 USD
-0.13 (-4.83%)
Last: 10/23/2025, 8:00:02 PM
Fundamental Rating

5

SNYR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Personal Care Products industry. SNYR has only an average score on both its financial health and profitability. SNYR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SNYR had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: SNYR reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: SNYR reported negative operating cash flow in multiple years.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

With an excellent Return On Assets value of 16.42%, SNYR belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
SNYR has a better Return On Invested Capital (32.60%) than 96.97% of its industry peers.
Industry RankSector Rank
ROA 16.42%
ROE N/A
ROIC 32.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

SNYR's Profit Margin of 9.61% is amongst the best of the industry. SNYR outperforms 84.85% of its industry peers.
Looking at the Operating Margin, with a value of 17.75%, SNYR belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
In the last couple of years the Operating Margin of SNYR has grown nicely.
SNYR has a better Gross Margin (70.31%) than 60.61% of its industry peers.
SNYR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.75%
PM (TTM) 9.61%
GM 70.31%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNYR is creating value.
The number of shares outstanding for SNYR has been increased compared to 1 year ago.
Compared to 5 years ago, SNYR has more shares outstanding
The debt/assets ratio for SNYR has been reduced compared to a year ago.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

SNYR has an Altman-Z score of 1.03. This is a bad value and indicates that SNYR is not financially healthy and even has some risk of bankruptcy.
SNYR has a worse Altman-Z score (1.03) than 75.76% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACC3.3
WACC9.88%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 2.74 indicates that SNYR has no problem at all paying its short term obligations.
SNYR's Current ratio of 2.74 is fine compared to the rest of the industry. SNYR outperforms 69.70% of its industry peers.
SNYR has a Quick Ratio of 2.41. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SNYR (2.41) is better than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.41
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

SNYR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.60%.
Looking at the last year, SNYR shows a very negative growth in Revenue. The Revenue has decreased by -18.57% in the last year.
SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SNYR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.50% on average per year.
The Revenue is expected to grow by 20.94% on average over the next years. This is a very strong growth
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 20M 40M 60M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.74, which indicates a rather cheap valuation of SNYR.
SNYR's Price/Earnings ratio is rather cheap when compared to the industry. SNYR is cheaper than 96.97% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.83, SNYR is valued rather cheaply.
The Price/Forward Earnings ratio is 5.58, which indicates a rather cheap valuation of SNYR.
96.97% of the companies in the same industry are more expensive than SNYR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.82. SNYR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.74
Fwd PE 5.58
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNYR indicates a somewhat cheap valuation: SNYR is cheaper than 69.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.53
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SNYR's earnings are expected to grow with 41.50% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3Y41.5%

0

5. Dividend

5.1 Amount

No dividends for SNYR!.
Industry RankSector Rank
Dividend Yield N/A

SYNERGY CHC CORP

NASDAQ:SNYR (10/23/2025, 8:00:02 PM)

2.56

-0.13 (-4.83%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners3.82%
Inst Owner ChangeN/A
Ins Owners7%
Ins Owner Change0.02%
Market Cap28.65M
Revenue(TTM)33.70M
Net Income(TTM)3.24M
Analysts82.86
Price Target10.2 (298.44%)
Short Float %3.13%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)74.19%
Min EPS beat(2)40.06%
Max EPS beat(2)108.33%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.71%
Min Revenue beat(2)-26.16%
Max Revenue beat(2)-11.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-90.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.22%
Valuation
Industry RankSector Rank
PE 6.74
Fwd PE 5.58
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.53
EPS(TTM)0.38
EY14.84%
EPS(NY)0.46
Fwd EY17.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.01
BVpS-1.11
TBVpS-1.13
PEG (NY)0.49
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 16.42%
ROE N/A
ROCE 47.47%
ROIC 32.6%
ROICexc 36.28%
ROICexgc 36.9%
OM 17.75%
PM (TTM) 9.61%
GM 70.31%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-ScoreN/A
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.4
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.74
Quick Ratio 2.41
Altman-Z 1.03
F-ScoreN/A
WACC9.88%
ROIC/WACC3.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year68.78%
EBIT Next 3Y35.04%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A